CompoAtlas

Good-Night

Food supplement declared in France, declaration No 2022-9-1891, decision dated 27 September 2022

Good-Night is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). 1 rule of use applies to its ingredients (limits and warnings).

Brand
not provided
Food business operator placing the product on the market
Secom Healthcare SRL
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Pilule
Daily dose
1
Directions for use
30 minutes avant d'aller se coucher
Not recommended for (according to the manufacturer)
Adolescents (moins de 18 ans), Femmes allaitantes, Femmes enceintes, Sous traitement médicamenteux
Objectives stated by the manufacturer (these are not authorised claims)
Sommeil

Declaration 326699, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Valeriana officinalis L.RacineAutre extrait sec300 mg
Humulus lupulus L.CôneAutre extrait sec100 mg
Passiflora incarnata L.Parties aériennesExtrait sec hydroalcoolique100 mg

Other active ingredients

NamePer day
Mélatoninenot declared

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
Bisglycinate de magnésiumMagnésium250 mg300 mg
Chlorhydrate de pyridoxineVitamine B612 mg2 mg

Additives

E341, E464, E460, E471, E551, E466, E470b

Other ingredients

Jus de betterave

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

List recorded in 2022. Photograph the packaging to check whether it has changed. Photograph the packaging

Label warnings

Les personnes suivant un traitement allopathique (en particulier des sédatifs), qui vont subir une intervention chirurgicale, qui souffrent d'une affection médicale (en particulier des affections hormono-dépendantes) ne peuvent utiliser le produit que sur recommandation d'un spécialiste.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Other declarations with the same name

This name is used by more than 10 declarations from different companies, so it does not identify one product. See every declaration with this name.

List recorded in 2022. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line